Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study
Abstract Ascorbic acid represents an appealing option for clinicians to utilize in the context of the global COVID-19 pandemic due to its proposed clinical efficacy, relative safety, and low cost. The aim of this study was to evaluate the efficacy and safety of using ascorbic acid in supplemental do...
Saved in:
Main Authors: | Khalid Al Sulaiman, Ohoud Aljuhani, Khalid Bin Saleh, Hisham A. Badreldin, Abdullah Al Harthi, Mohammed Alenazi, Aisha Alharbi, Rahmah Algarni, Shmeylan Al Harbi, Abdullah M. Alhammad, Ramesh Vishwakarma, Sarah Aldekhyl |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/01acb48b22bb49dda4056fb524eebae5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Author Correction: Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study
by: Khalid Al Sulaiman, et al.
Published: (2021) -
Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study
by: Ohoud Aljuhani, et al.
Published: (2021) -
The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study
by: Khalid Al Sulaiman, et al.
Published: (2021) -
Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study
by: Khalid Al Sulaiman, et al.
Published: (2021) -
Major Cardiovascular Advances: Highlights from the 2019 American College of Cardiology Annual Scientific Session
by: Hisham A Badreldin, et al.
Published: (2020)